small molecule

PRILOSEC

OMEPRAZOLE MAGNESIUM

Loss of exclusivityloss of exclusivity
CompanyAZURITY PHARMACEUTICALS SWITZERLAND GMBH

Drug detail

Brand namePRILOSEC
Active ingredientOMEPRAZOLE MAGNESIUM
StrengthEQ 10MG BASE/PACKET
Dosage formFOR SUSPENSION, DELAYED RELEASE
RouteORAL
ModalitySmall molecule
FDA approvalMarch 2008
Marketing statusRX

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.

PRILOSEC patent cliff — loss of exclusivity — | CliffBio